COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response.
COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response.
复制标题
DOI:
10.3390/vaccines8040649
复制
发表时间:
2020-11-03
期刊:
影响因子:
7.8
通讯作者:
Chand S
中科院分区:
文献类型:
--
作者:
Jain S;Batra H;Yadav P;Chand S
With a death toll of over one million worldwide, the COVID-19 pandemic caused by SARS-CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The fear of acquiring infection and spreading to vulnerable people has severely impacted society’s socio-economic status. To put an end to this growing number of infections and deaths as well as to switch from restricted to everyday living, an effective vaccine is desperately needed. As a result, enormous efforts have been made globally to develop numerous vaccine candidates in a matter of months. Currently, over 30 vaccine candidates are under assessment in clinical trials, with several undergoing preclinical studies. Here, we reviewed the major vaccine candidates based on the specific vaccine platform utilized to develop them. We also discussed the immune responses generated by these candidates in humans and preclinical models to determine vaccine safety, immunogenicity, and efficacy. Finally, immune responses induced in recovered COVID-19 patients and their possible vaccine development implications were also briefly reviewed.
登录
查看更多内容
影响因子:
56.9
作者:
Hsieh, Ching-Lin;Goldsmith, Jory A.;McLellan, Jason S.
通讯作者:
McLellan, Jason S.
影响因子:
4.6
作者:
Cunningham, Anthony L.
通讯作者:
Cunningham, Anthony L.
DOI:
10.1038/nrmicro2090
发表时间:
2009-03
期刊:
Nature reviews. Microbiology
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.8
作者:
Ewer K;Sebastian S;Spencer AJ;Gilbert S;Hill AVS;Lambe T
通讯作者:
Lambe T
影响因子:
56.3
作者:
Folegatti, Pedro M.;Bittaye, Mustapha;Gilbert, Sarah
通讯作者:
Gilbert, Sarah